CHARACTERISTICS OF GUT MICROBIOTA ASSOCIATED WITH FUNCTIONAL CURE IN CHRONIC HEPATITIS B PATIENTS WITH HBEAG- NEGATIVE; POSSIBLE INHIBITION OF HEPATITIS B VIRUS BY BUTYRATE- PRODUCING BACTERIA

被引:0
|
作者
Honda, Takashi [1 ]
Murayama, Asako [2 ]
Inukai, Yosuke [1 ]
Muto, Hisanori [1 ]
Yokoyama, Shinya [1 ]
Yamamoto, Kenta [1 ]
Ito, Takanori [1 ]
Imai, Norihiro [1 ]
Ishizu, Yoji [1 ]
Ishigami, Masatoshi [1 ]
Yoshio, Sachiyo [3 ]
Ishikawa, Tetsuya [1 ]
Kawashima, Hiroki [1 ]
Kato, Takanobu [2 ]
机构
[1] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan
[2] Natl Inst Infect Dis, Tokyo, Japan
[3] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1494C
引用
收藏
页码:S594 / S594
页数:1
相关论文
共 50 条
  • [21] Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B
    Wagner, Josef
    Yuen, Lilly
    Littlejohn, Margaret
    Sozzi, Vitina
    Jackson, Kathy
    Martin, Ross
    Aeschbacher, Thomas
    Suri, Vithika
    Tan, Susanna K.
    Feierbach, Becket
    Gaggar, Anuj
    Marcellin, Patrick
    Ferret, Maria Buti
    Janssen, Harry L. A.
    Gane, Ed
    Meagher, Niamh
    Price, David J.
    Wong, Darren
    Thompson, Alexander T.
    Revill, Peter A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (05) : 509 - 523
  • [22] Therapeutic strategies for a functional cure of chronic hepatitis B virus infection
    Chang, Jinhong
    Guo, Fang
    Zhao, Xuesen
    Guo, Ju-Tao
    ACTA PHARMACEUTICA SINICA B, 2014, 4 (04) : 248 - 257
  • [23] Association of hepatitis B core antibody level and hepatitis B surface antigen clearance in HBeAg-negative patients with chronic hepatitis B
    Wang, Jian
    Zhang, Zhiyi
    Zhu, Li
    Zhang, Qing
    Zhang, Shaoqiu
    Pan, Yifan
    Liu, Jiacheng
    Cao, Fei
    Fan, Tao
    Xiong, Ye
    Yin, Shengxia
    Yan, Xiaomin
    Chen, Yuxin
    Zhu, Chuanwu
    Li, Jie
    Liu, Xingxiang
    Wu, Chao
    Huang, Rui
    VIRULENCE, 2024, 15 (01)
  • [24] Lack of ethnic differences in response to adefovir dipivoxil therapy in HBeAg+ and HBeAg- patients with chronic hepatitis B.
    Lim, SG
    Marcellin, P
    Tassopoulos, N
    Hadziyannis, S
    Chang, TT
    Tong, M
    Sievert, W
    Hu, P
    Currie, G
    James, C
    Choy, GS
    Kearney, B
    Chen, SS
    Brosgart, CL
    HEPATOLOGY, 2003, 38 (04) : 714A - 715A
  • [25] Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis
    Zhang, Zhan-qing
    Wang, Yan-bing
    Lu, Wei
    Liu, Dan-ping
    Shi, Bi-sheng
    Zhang, Xiao-nan
    Huang, Dan
    Li, Xiu-fen
    Zhou, Xin-lan
    Ding, Rong-rong
    ANNALS OF LABORATORY MEDICINE, 2019, 39 (01) : 67 - 75
  • [26] Hepatitis B virus splice variants are associated with reduced likelihood of functional cure and differ across phases of chronic hepatitis B infection
    Maslac, Olivia
    Wagner, Josef
    Sozzi, Vitina
    Mason, Hugh
    Svarovskaia, Evguenia S.
    Tan, Susanna
    Gaggar, Anuj
    Locarnini, Stephen
    Yuen, Lilly
    Littlejohn, Margaret
    Revill, Peter
    JOURNAL OF HEPATOLOGY, 2022, 77 : S251 - S252
  • [27] Hepatitis B virus mutations associated with lamivudine therapy in patients with chronic hepatitis B
    Asahina, Y
    Enomoto, N
    Nagayama, K
    Kurosaki, M
    Ogura, Y
    Izumi, N
    Marumo, F
    Sato, C
    HEPATOLOGY RESEARCH, 1999, 15 (02) : 145 - 156
  • [28] Amino Acid Polymorphism in Hepatitis B Virus Associated With Functional Cure
    Honda, Takashi
    Yamada, Norie
    Murayama, Asako
    Shiina, Masaaki
    Aly, Hussein Hassan
    Kato, Asuka
    Ito, Takanori
    Ishizu, Yoji
    Kuzuya, Teiji
    Ishigami, Masatoshi
    Murakami, Yoshiki
    Tanaka, Tomohisa
    Moriishi, Kohji
    Nishitsuji, Hironori
    Shimotohno, Kunitada
    Ishikawa, Tetsuya
    Fujishiro, Mitsuhiro
    Muramatsu, Masamichi
    Wakita, Takaji
    Kato, Takanobu
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2021, 12 (05): : 1583 - 1598
  • [29] HEPATITIS-B VIRUS PRECORE MUTATIONS AND HBEAG NEGATIVE REACTIVATION OF CHRONIC HEPATITIS-B AFTER INTERFERON THERAPY
    TALBODEC, N
    LORIOT, MA
    GIGOU, M
    GUIGONIS, V
    BOYER, N
    BEZEAUD, A
    ERLINGER, S
    BENHAMOU, JP
    MARCELLIN, P
    LIVER, 1995, 15 (02): : 93 - 98
  • [30] Hepatitis B Virus RNA as Early Predictor for Response to Pegylated Interferon Alpha in HBeAg-Negative Chronic Hepatitis B
    Farag, Mina S.
    van Campenhout, Margo J. H.
    Pfefferkorn, Maria
    Fischer, Janett
    Deichsel, Danilo
    Boonstra, Andre
    van Vuuren, Anneke J.
    Ferenci, Peter
    Feld, Jordan J.
    Berg, Thomas
    Hansen, Bettina E.
    van Bommel, Florian
    Janssen, Harry L. A.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (02) : 202 - 211